Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of October 26, 2026, SNDX trades at $13.51 with a market cap of $1.20B and a P/E ratio of -6.91. SNDX moved +0.81% today. Year to date, SNDX is -36.22%; over the trailing twelve months it is -8.72%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $38.29. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SNDX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $13.51 |
| Market Cap | $1.20B |
| P/E Ratio | -6.91 |
| EPS | $-2.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.59 |
| 52-Week Low | $8.58 |
| Volume | 12.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $252.25M |
| Net Income | $-220.76M |
| Gross Margin | 0.00% |
8 analysts cover SNDX: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.29.